A Molecular Classifier That Identifies Usual Interstitial Pneumonia in Transbronchial Biopsy Specimens of Patients With Interstitial Lung Disease
- PMID: 32386639
- DOI: 10.1016/j.chest.2019.10.061
A Molecular Classifier That Identifies Usual Interstitial Pneumonia in Transbronchial Biopsy Specimens of Patients With Interstitial Lung Disease
Comment on
-
POINT: Should Molecular and Genetic Biomarkers Be Used in the Initial Evaluation of Patients With Fibrotic ILD? Yes.Chest. 2019 Aug;156(2):203-205. doi: 10.1016/j.chest.2019.03.026. Chest. 2019. PMID: 31395255 No abstract available.
-
COUNTERPOINT: Should Molecular and Genetic Biomarkers Be Used in the Initial Evaluation of Patients With Fibrotic ILD? No.Chest. 2019 Aug;156(2):205-208. doi: 10.1016/j.chest.2019.03.027. Chest. 2019. PMID: 31395256 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
